» Articles » PMID: 23743171

Amelioration of Cognitive, Motor and Endogenous Defense Functions with Silymarin, Piracetam and Protocatechuic Acid in the Cerebral Global Ischemic Rat Model

Overview
Journal Life Sci
Publisher Elsevier
Date 2013 Jun 8
PMID 23743171
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The neuroprotective activities of silymarin, piracetam and protocatechuic acid ethyl ester (PCA) on cerebral global ischemic/reperfusion were evaluated in a rat model.

Main Methods: A midline ventral incision was made in the throat region. The right and left common carotid arteries were located and a bilateral common carotid artery occlusion (BCCAO) was performed for 30min using atraumatic clamps followed by a 24h period of reperfusion. Neurological/behavioral functions (cognitive and motor), endogenous defense systems (lipid peroxidation, glutathione, catalase, and superoxide dismutase), reduced water content and infarct size and histopathological alterations were then studied.

Key Findings: Silymarin and PCA treatments significantly improved cognitive, motor and endogenous defense functions, histopathological alterations, and, reduced both water content and infarct size compared to the vehicle-treated ischemic control group. Piracetam treatment improved neurological and histopathological alterations, reduced water content and infarct size, but failed to restore/prevent the impaired endogenous defense functions significantly.

Significance: Silymarin showed better neuroprotection than piracetam and PCA in experimentally induced global ischemic/reperfusion and was able to facilitate mnemonic performance.

Citing Articles

Silymarin administration after cerebral ischemia improves survival of obese mice by increasing cortical BDNF and IGF1 levels.

Rodriguez-Cortes Y, Ramirez-Carreto R, Rodriguez-Barrena J, Salazar-Castro M, Chavarria A Front Aging Neurosci. 2024; 16:1484946.

PMID: 39624169 PMC: 11609184. DOI: 10.3389/fnagi.2024.1484946.


Research Progress on the Mechanisms of Protocatechuic Acid in the Treatment of Cognitive Impairment.

Liang S, Zhao Z, Liu L, Zhang Y, Liu X Molecules. 2024; 29(19).

PMID: 39407652 PMC: 11478363. DOI: 10.3390/molecules29194724.


Piracetam reduces oxidative stress and mitochondrial function impairment in an in vitro model of vascular dementia.

Liu J, Yang N, Wang X, Wang W Exp Brain Res. 2024; 242(8):1841-1850.

PMID: 38842755 DOI: 10.1007/s00221-024-06868-x.


Reno-protective effect of protocatechuic acid is independent of sex-related differences in murine model of UUO-induced kidney injury.

Saad K, Lopes Salles E, Naeini S, Baban B, Abdelmageed M, Abdelaziz R Pharmacol Rep. 2024; 76(1):98-111.

PMID: 38214881 DOI: 10.1007/s43440-023-00565-2.


Administration of α-lipoic acid and silymarin attenuates aggression by modulating endocrine, oxidative stress and inflammatory pathways in mice.

Karim A, Anwar F, Saleem U, Fatima S, Ismail T, Obaidullah A Metab Brain Dis. 2023; 38(7):2255-2267.

PMID: 37458892 DOI: 10.1007/s11011-023-01258-8.